Drug Type Synthetic peptide |
Synonyms ME 003, ME003 |
Target |
Action agonists |
Mechanism FGF21R agonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | China | 01 Nov 2024 |






